These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9240663)

  • 1. Treatment of radiation-induced enterocolitis.
    Michalowski AS
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):908-9. PubMed ID: 9240663
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation.
    Indriolo A; Fagiuoli S; Pasulo L; Fiorino G; Danese S; Ravelli P
    Aliment Pharmacol Ther; 2013 Apr; 37(8):840-2. PubMed ID: 23496317
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of therapeutic/prophylactic dragee "honey laminolact" in radiotherapy of uterine tumors].
    Smirnova II; Filatova EI; Suvorov AN; Bylinskaia EN
    Vopr Onkol; 2000; 46(6):748-50. PubMed ID: 11219953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New inflammatory bowel disease drugs targeting the inflammatory cascade].
    Desreumaux P
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B72-8. PubMed ID: 11449147
    [No Abstract]   [Full Text] [Related]  

  • 5. ISIS 2302. Oligo-TCS.
    Drugs R D; 1999 Mar; 1(3):265-7. PubMed ID: 10566042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of infliximab in treatment on inflammatory bowel disease and factors affecting the therapeutic effect].
    Zhou Y; Chen Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1833-8. PubMed ID: 24369257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced enterocolitis: basic and applied science.
    Szabo S; Sandor Z; Vincze A; Gombos Z; Mohiuddin A; Viravathana T
    Eur J Surg Suppl; 1998; (582):85-9. PubMed ID: 10029371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of inflammatory bowel disease care.
    Sandborn WJ
    Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto Group.
    de Ridder L; Waterman M; Turner D; Bronsky J; Hauer AC; Dias JA; Strisciuglio C; Ruemmele FM; Levine A; Lionetti P;
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):503-8. PubMed ID: 26154031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?].
    Kim YS
    Korean J Gastroenterol; 2018 Feb; 71(2):74-80. PubMed ID: 29471604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The up-to-date methods of management of NSAIDs-induced injuries of small intestine].
    Tkach SM; Balabantseva HP; Levchenko AR
    Lik Sprava; 2014; (5-6):38-47. PubMed ID: 25906646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory drug treatment of radiation injuries.
    Michalowski AS
    Adv Exp Med Biol; 1997; 400B():873-7. PubMed ID: 9547641
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor necrosis factor, infliximab, and adalimumab: use with caution in eosinophilic bowel disease.
    Furuta GT; Atkins D; Capocelli KE; de Zoeten EF; Fleischer D; Menard-Katcher C
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):e25. PubMed ID: 23820407
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease.
    Kolho KL; Ruuska T; Savilahti E
    Acta Paediatr; 2007 Jan; 96(1):128-30. PubMed ID: 17187619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authors' response.
    Turner D; Friesen C
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):e25-6. PubMed ID: 23820406
    [No Abstract]   [Full Text] [Related]  

  • 17. [Classical medications in the treatment of inflammatory bowel diseases].
    Duvnjak M; Bilić A; Barsić N; Tomasić V; Stojsavljević S
    Acta Med Croatica; 2013 Apr; 67(2):111-24. PubMed ID: 24471294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regarding Martenson et al., IJROBP 35:299-303; 1996.
    Michalowski AS
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1285-6. PubMed ID: 8985061
    [No Abstract]   [Full Text] [Related]  

  • 19. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.
    Navarini AA; Hruz P; Berger CT; Hou TZ; Schwab C; Gabrysch A; Higgins R; Frede N; Padberg Sgier BC; Kämpe O; Burgener AV; Marquardsen F; Baldin F; Bigler M; Kistner A; Jauch A; Bignucolo O; Meyer B; Meienberg F; Mehling M; Jeker LT; Heijnen I; Daikeler TD; Gebbers JO; Grimbacher B; Sansom DM; Jeker R; Hess C; Recher M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1043-1046.e5. PubMed ID: 27908448
    [No Abstract]   [Full Text] [Related]  

  • 20. Conventional drug therapy in inflammatory bowel disease.
    Griffin MG; Miner PB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):509-21. PubMed ID: 8809233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.